|
|
 |
|
Viewing report
|
|
|
|
Progenics Pharmaceuticals, Inc. - SWOT Analysis
Datamonitor, Aug 2011, Pages: 22
Progenics Pharmaceuticals, Inc. - SWOT Analysis company profile is the essential source for top-level company data and information. Progenics Pharmaceuticals, Inc. - SWOT Analysis examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.
Progenics Pharmaceuticals (Progenics) is a biopharmaceutical company focusing on the development and commercialization of therapeutic products. The company operates in the US. It is headquartered in Tarrytown, New York and employed 159 people as of December 31, 2010. The company recorded revenues of $8 million during the financial year ended December 2010 (FY2010), a decrease of 83.8% compared with FY2009. The operating loss of the company was $69.9 million during FY2010, as compared to operating loss of $32.3 million in FY2009. The net loss was $69.7 million in FY2010, as compared to net loss of $30.6 million in FY2009.
Scope of the Report
- Provides all the crucial information on Progenics Pharmaceuticals, Inc. required for business and competitor intelligence needs
- Contains a study of the major internal and external factors affecting Progenics Pharmaceuticals, Inc. in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams of Progenics Pharmaceuticals, Inc.
-Data is supplemented with details on Progenics Pharmaceuticals, Inc. history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available statement from Progenics Pharmaceuticals, Inc.
Reasons to Purchase
- Support sales activities by understanding your customers’ businesses better
- Understand prospective partners and suppliers
- Keep fully up to date on your competitors’ business structure, strategy and prospects
- Obtain the most up to date company information available
Customers who bought this item also bought
Progenics Pharmaceuticals, Inc. - Strategy and SWOT Report
Progenics Pharmaceuticals, Inc. - Strategy, SWOT, and Corporate Finance Report
Progenics Pharmaceuticals, Inc. (PGNX) - Financial and Strategic SWOT Analysis Review
Vertex Pharmaceuticals, Inc. - SWOT Analysis
ISTA Pharmaceuticals, Inc. - SWOT Analysis
Progen Pharmaceuticals Limited (PGL) - Financial and Strategic SWOT Analysis Review
Enzon Pharmaceuticals, Inc. - SWOT Analysis
Knoll, Inc. - SWOT Analysis
Vivus, Inc. - SWOT Analysis
Monster Worldwide, Inc. - SWOT Analysis
|
|
|
|
